How are patients followed after treatment?
Regular follow-up is an important part of thyroid cancer treatment. It should always be kept in mind that the cancer can sometimes come back years after surgery. Follow-up has four main elements:
- Assessment of general health and examination of the lymph nodes in the neck
- Blood tests
- Neck ultrasound and other imaging
- Nuclear medicine whole-body scans
Your doctor first reviews your general condition after surgery and the status of treatments such as thyroid hormone or calcium. Hormone treatment given after total thyroidectomy is monitored with blood tests at intervals. Depending on the extent and size of the disease, it is given at a high dose in order to suppress TSH, a pituitary hormone. Another blood test used in follow-up is the thyroglobulin level. Thyroglobulin is a protein made only by thyroid cells, and most thyroid cancers that arise from thyroid cells continue to produce it. After successful treatment the aim is therefore a thyroglobulin level of zero or close to zero. (In medullary thyroid cancer, which arises from C cells, the calcitonin level is followed instead.)
Examination of the neck lymph nodes and imaging are important tools in follow-up. Finding the site of disease matters particularly in patients whose thyroglobulin level is rising. Neck ultrasound is a very sensitive method for detecting metastatic lymph nodes, that is, nodes containing cancer. Your doctor may sometimes also request a contrast-enhanced CT scan, in addition to ultrasound or to image the lymph nodes in the front of the chest (the mediastinum).
Nuclear medicine studies have an important place in the follow-up of thyroid cancer. After radioactive iodine ablation, the whole body is scanned with a gamma camera to look for uptake. Whole-body scans with a low dose of radioactive material may be repeated when your doctor considers it necessary.
What are the results of treatment?
Taken as a whole, the results of thyroid cancer treatment are very good, especially in patients under 55 and in tumours found at an early stage. In younger patients (under 55) with an early-stage tumour confined to the thyroid, 10-year survival is above 90%. Survival can be lower in older men and in aggressive tumour types that extend beyond the thyroid. The risk of recurrence rises after inadequate surgery or treatment. You should talk in detail with your doctor about the stage of your disease and the treatments. Even after successful treatment, thyroid cancer needs lifelong follow-up and regular check-ups.
If the disease comes back
Surgery remains the first choice in recurrent thyroid cancer. Patients whose first operation was inadequate, or whose disease recurs in the lymph nodes, need further surgery. We recommend that these operations, known as recurrent or revision thyroid surgery, be performed under intraoperative nerve monitoring by surgeons who specialise in the field.